Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 17:14:42 UTC
Update Date2021-09-26 23:12:33 UTC
HMDB IDHMDB0256694
Secondary Accession NumbersNone
Metabolite Identification
Common NamePomalidomide
DescriptionPomalidomide, also known as pomalyst or CC 4047, belongs to the class of organic compounds known as phthalimides. These are aromatic heterocyclic compounds containing a 1,3-dioxoisoindoline moiety. They are imide derivatives of phthalic anhydrides. Based on a literature review a significant number of articles have been published on Pomalidomide. This compound has been identified in human blood as reported by (PMID: 31557052 ). Pomalidomide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Pomalidomide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
3-Amino-N-(2,6-dioxo-3-piperidyl)phthalimideChEBI
4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dioneChEBI
4-AminothalidomideChEBI
CC 4047ChEBI
CC-4047ChEBI
PomalystChEBI
S-3-amino-phthalimido-GlutarimideMeSH
3-AminophthalimidoglutarimideMeSH
S-3APGMeSH
3-aminio-phthalimido-GlutarimideMeSH
Chemical FormulaC13H11N3O4
Average Molecular Weight273.2441
Monoisotopic Molecular Weight273.074955855
IUPAC Name4-amino-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione
Traditional Namepomalidomide
CAS Registry NumberNot Available
SMILES
NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O
InChI Identifier
InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18)
InChI KeyUVSMNLNDYGZFPF-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as phthalimides. These are aromatic heterocyclic compounds containing a 1,3-dioxoisoindoline moiety. They are imide derivatives of phthalic anhydrides.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassIsoindoles and derivatives
Sub ClassIsoindolines
Direct ParentPhthalimides
Alternative Parents
Substituents
  • Phthalimide
  • Alpha-amino acid or derivatives
  • Isoindole
  • Piperidinedione
  • Delta-lactam
  • Piperidinone
  • Benzenoid
  • Piperidine
  • Carboxylic acid imide, n-substituted
  • Carboxylic acid imide
  • Dicarboximide
  • Vinylogous amide
  • Carboxylic acid imide, n-unsubstituted
  • Amino acid or derivatives
  • Lactam
  • Carboxylic acid derivative
  • Azacycle
  • Primary amine
  • Amine
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic nitrogen compound
  • Carbonyl group
  • Organic oxygen compound
  • Organooxygen compound
  • Organonitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP0.02ALOGPS
logP-0.16ChemAxon
logS-2ALOGPS
pKa (Strongest Acidic)11.59ChemAxon
pKa (Strongest Basic)1.56ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area109.57 ŲChemAxon
Rotatable Bond Count1ChemAxon
Refractivity69.03 m³·mol⁻¹ChemAxon
Polarizability25.81 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+165.08430932474
DeepCCS[M-H]-162.72630932474
DeepCCS[M-2H]-195.61230932474
DeepCCS[M+Na]+171.17730932474
AllCCS[M+H]+161.232859911
AllCCS[M+H-H2O]+157.632859911
AllCCS[M+NH4]+164.432859911
AllCCS[M+Na]+165.432859911
AllCCS[M-H]-161.432859911
AllCCS[M+Na-2H]-160.932859911
AllCCS[M+HCOO]-160.332859911

Predicted Kovats Retention Indices

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Pomalidomide,1TMS,isomer #1C[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O2841.2Semi standard non polar33892256
Pomalidomide,1TMS,isomer #1C[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O2838.0Standard non polar33892256
Pomalidomide,1TMS,isomer #1C[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O4437.5Standard polar33892256
Pomalidomide,1TMS,isomer #2C[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N)=C3C2=O)C1=O2684.2Semi standard non polar33892256
Pomalidomide,1TMS,isomer #2C[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N)=C3C2=O)C1=O2624.6Standard non polar33892256
Pomalidomide,1TMS,isomer #2C[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N)=C3C2=O)C1=O4136.4Standard polar33892256
Pomalidomide,2TMS,isomer #1C[Si](C)(C)N(C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)[Si](C)(C)C2682.7Semi standard non polar33892256
Pomalidomide,2TMS,isomer #1C[Si](C)(C)N(C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)[Si](C)(C)C2882.1Standard non polar33892256
Pomalidomide,2TMS,isomer #1C[Si](C)(C)N(C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)[Si](C)(C)C4084.8Standard polar33892256
Pomalidomide,2TMS,isomer #2C[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)N([Si](C)(C)C)C1=O)C2=O2715.4Semi standard non polar33892256
Pomalidomide,2TMS,isomer #2C[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)N([Si](C)(C)C)C1=O)C2=O2831.7Standard non polar33892256
Pomalidomide,2TMS,isomer #2C[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)N([Si](C)(C)C)C1=O)C2=O3716.4Standard polar33892256
Pomalidomide,3TMS,isomer #1C[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N([Si](C)(C)C)[Si](C)(C)C)=C3C2=O)C1=O2583.7Semi standard non polar33892256
Pomalidomide,3TMS,isomer #1C[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N([Si](C)(C)C)[Si](C)(C)C)=C3C2=O)C1=O2907.0Standard non polar33892256
Pomalidomide,3TMS,isomer #1C[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N([Si](C)(C)C)[Si](C)(C)C)=C3C2=O)C1=O3417.6Standard polar33892256
Pomalidomide,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O3077.1Semi standard non polar33892256
Pomalidomide,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O3057.5Standard non polar33892256
Pomalidomide,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O4349.4Standard polar33892256
Pomalidomide,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N)=C3C2=O)C1=O2921.4Semi standard non polar33892256
Pomalidomide,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N)=C3C2=O)C1=O2819.9Standard non polar33892256
Pomalidomide,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N)=C3C2=O)C1=O4088.5Standard polar33892256
Pomalidomide,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)[Si](C)(C)C(C)(C)C3145.1Semi standard non polar33892256
Pomalidomide,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)[Si](C)(C)C(C)(C)C3275.3Standard non polar33892256
Pomalidomide,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)[Si](C)(C)C(C)(C)C3999.2Standard polar33892256
Pomalidomide,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)N([Si](C)(C)C(C)(C)C)C1=O)C2=O3125.0Semi standard non polar33892256
Pomalidomide,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)N([Si](C)(C)C(C)(C)C)C1=O)C2=O3229.6Standard non polar33892256
Pomalidomide,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)N([Si](C)(C)C(C)(C)C)C1=O)C2=O3678.2Standard polar33892256
Pomalidomide,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C2=O)C1=O3244.5Semi standard non polar33892256
Pomalidomide,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C2=O)C1=O3475.1Standard non polar33892256
Pomalidomide,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C2=O)C1=O3533.6Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Pomalidomide GC-MS (Non-derivatized) - 70eV, Positivesplash10-0gej-4980000000-d041e1fb3b612b5f8e222017-08-28Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Pomalidomide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Pomalidomide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Pomalidomide LC-ESI-qTof , Positive-QTOFsplash10-0udi-1590000000-a511655f5e07f3ab21792017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Pomalidomide , positive-QTOFsplash10-0udi-1590000000-a511655f5e07f3ab21792017-09-14HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Pomalidomide 10V, Positive-QTOFsplash10-05fr-0090000000-7d14af32a1640f645afc2017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Pomalidomide 20V, Positive-QTOFsplash10-0ab9-0190000000-734f84ec8cd6426840842017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Pomalidomide 40V, Positive-QTOFsplash10-0f76-8940000000-362915b4187ee23f2fcf2017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Pomalidomide 10V, Negative-QTOFsplash10-00di-0190000000-c438caf9103271bcb6652017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Pomalidomide 20V, Negative-QTOFsplash10-0h90-1390000000-eb3387d4568613b0761f2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Pomalidomide 40V, Negative-QTOFsplash10-03dl-9700000000-b666e9e333f7bcb1b3c52017-07-26Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB08910
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID118785
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkPomalidomide
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI ID72690
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]